Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Non-Current Debt (2020 - 2021)

Silo Pharma (SILO) has disclosed Non-Current Debt for 2 consecutive years, with $1063.0 as the latest value for Q1 2021.

  • Quarterly Non-Current Debt changed N/A to $1063.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $1063.0 through Mar 2021, changed N/A year-over-year, with the annual reading at $4246.0 for FY2020, N/A changed from the prior year.
  • Non-Current Debt hit $1063.0 in Q1 2021 for Silo Pharma, down from $4246.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $11642.0 in Q2 2020 to a low of $1063.0 in Q1 2021.